I am a Psychologist and the Coordinator of the DBT Program at the VA Puget Sound Health Care System as well as an Associate Professor in the Department of Psychiatry and Behavioral Sciences and Adjunct Associate Professor in the Department of Psychology at the University of Washington. I previously worked as the Research Director of Dr. Marsha Linehan’s Behavioral Research and Therapy Clinics at the University of Washington (2006-2018), Director of Research and Development for Behavioral Tech, LLC (2014-2017), and Director of Behavioral Tech Research, Inc. (2013-2016). My research focuses on the development and evaluation of the DBT Prolonged Exposure protocol for PTSD as well as methods of disseminating and implementing this and other evidence-based treatments into clinical practice. I regularly provide training and consultation nationally and internationally in DBT and DBT PE and have published extensively on these treatments. I am a certified DBT therapist, a certified PE therapist and supervisor, am board certified in Behavioral and Cognitive therapy, and am licensed as a psychologist in the state of Washington.
My work focuses on the diagnosis and treatment of post traumatic stress disorder (PTSD), mild traumatic brain injury (mTBI), and neurodegenerative dementias, as well as applications of positron emission tomography (PET) and other functional neuroimaging modalities to elucidating the pathophysiology of PTSD, mTBI, Alzheimer’s Disease, and other neurodegenerative dementias.
I am a child and adolescent psychiatrist at Seattle Children’s Hospital and faculty member at the University of Washington Medicine. My SCH practice locations include the Gender Clinic (Adolescent Medicine), Outpatient Psychiatry Clinic, Autism Center, and the inpatient unit- Psychiatry and Behavioral Medicine Unit (PBMU). I believe in delivering compassionate, evidence-based care in supporting patients and their families. My approach is both comprehensive and patient-centered, as it is important to consider the needs of the individual while also appreciating societal and cultural context. I specialize in working with diverse patient populations with various marginalized identities, such as those who identify as LGBTQ, gender diverse, and/or neurodiverse. I also work closely with the Adolescent Medicine Gender Clinic in supporting any mental health needs of transgender/gender diverse youth and their families. I also collaborate with colleagues in specialty medical clinics to coordinate care of medically complex patients. Additionally, I serve as a consultant with various school programs to support mental health initiatives and advocacy efforts.
Academically, I am involved with several initiatives both locally and nationally, particularly those that work to promote diversity and equity. I serve on committees supporting the SCH/UW CAP Fellowship Program, educating trainees and students through direct clinical supervision as well as with lectures and discussions. On a national level, I serve on the Sexual Orientation and Gender Identity Issues Committee (SOGIIC) for the American Academy of Child and Adolescent Psychiatry (AACAP). My clinical research focuses on finding strategies to better support the mental health and well-being of patients and families who are LGBTQ+. Additionally, I work on studies that explore the intersection between gender diversity and neuro diversity/autism spectrum.
The Hendrickson research group explores underlying biological mechanisms related to the development and maintenance of posttraumatic stress disorder (PTSD) and related conditions, including mild traumatic brain injury, as well as the potential for interaction between different types of stress and trauma. Through the design and implementation of translational clinical studies, we apply this work directly to the pursuit of new treatment options for people who have experienced a traumatic stress.
A primary goal of our team is to understand broadly the ways traumatic stress interferes with people’s lives, and to prioritize the areas of greatest clinical need. We look for ways to prevent persistent symptoms after trauma, to match patients more quickly to the treatment options that will be most effective for them as individuals, and to develop new treatment options for those for whom current options are simply not adequate.
In addition to my research work, I am a staff psychiatrist in the VA PTSD Outpatient Clinic and a member of the VA Dialectical Behavioral Therapy (DBT) Team, and provide teaching and mentorship for residents in the UW Psychiatry Training Program.
Dr. Jenness is a clinical child psychologist and Associate Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington. She earned her Ph.D. in Clinical Psychology from the University of Denver in 2015. Her past research includes NIMH-funded studies on the neural and behavioral changes that predict treatment response to behavioral activation for depressed adolescents (K23/NARSAD). As the director of the Adolescent Depression and Intervention Innovations (ADII) lab, her recent work focuses on innovative digital treatment approaches to improve adolescent depression care. Current projects include 1) adapting behavioral activation to an online platform, ActivaTeen (R03, NIMH R34); 2) leveraging paraprofessional coaching of video-guided depression care (Garvey Innovation Grant); and 3) developing and testing a digital just-in-time adaptive intervention (Sidekick; NIMH R61) as a first-step adolescent depression treatment within primary care settings. In addition to research, Dr. Jenness is an Attending Psychologist in the Mood and Anxiety Disorders Program at Seattle Children’s Hospital where she primarily treats adolescent depression and suicide. She has also trained mental health professionals at various sites around the US in the use of behavioral activation with adolescents.
Personal Statement
I am a developmental and child clinical psychologist actively engaged in a clinical and research program designed to characterize the development, course, and management of clinical depression in young people. My colleagues and I are engaged in a series of research investigations documenting the developmental pathways of youth with depressive disorders and co-occurring conduct problems, testing the efficacy of a brief intervention, assessment and engagement approach for school-based for school based providers, and adapting and testing behavioral activation as a therapy for depressed adolescents. I am also engaged in a randomized control study assessing the efficacy of Dialectical Behavior Therapy as a treatment for youth with suicidal ideation and behaviors.
I have been actively involved with national and local efforts to disseminate training in evidenced based treatment strategies to child mental health care providers and is currently working with King County Public Health and local school districts to provide training and consultation to school based mental health providers in evidenced based assessment and intervention approaches. In addition to my work focused on depressive disorders, I have extensive experience evaluating and treating children/adolescents and their families who present with a variety of developmental and behavior problems including youth with gender dysphoria and those with disorders of sex development.
Personal Statement
I am a Professor of Psychiatry and Director of the Addictions Division in the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine in Seattle, Washington. I am also the clinical director of addictions treatment services at Harborview Medical Center, and work in the psychiatric rehabilitation and recovery services.
I am board-certified in Psychiatry by the American Board of Psychiatry and Neurology with Added Qualifications in Addiction Psychiatry, and the American Board of Addiction Medicine. A Distinguished Fellow of the American Psychiatric Association and a Fellow of the American Society of Addiction Medicine, I am on the editorial board and a reviewer for several scientific journals and holds a number of research grants from the National Institute of Health.
Robert Hilt, MD is a Professor in the UW Department of Psychiatry and Behavioral Sciences and a psychiatrist at Seattle Children’s Hospital. He is the program director for the Partnership Access Line (PAL), a child mental health consultation service for primary care providers in Washington, Wyoming and Alaska. He is the Program Director for the Medicaid Medication Second Opinion Programs of Wyoming, Washington and Alaska, and Multidisciplinary Team (MDT) Psychiatric Consult Service in Wyoming for children in foster care. He has been involved in several collaborative care projects, in school support projects, and has helped to establish a statewide mental health referral service in Washington. Dr. Hilt’s primary interest is to increase professional collaboration between child psychiatrists and pediatric medical providers, and to increase access to high quality care.
Personal Statement
I am an investigator in the Seattle-Denver Center of Innovation for Veteran-Centered and Value-Driven Care and Associate Director of the Seattle Center of Excellence in Substance Abuse Treatment and Education (CESATE), one of two national VA centers devoted to improving the quality of care and clinical outcomes of veterans with substance use conditions. I am also a licensed clinical psychologist in Washington State. My primary research interests include evaluating and improving behavioral health and substance use outcomes of Veterans with alcohol and/or drug misuse conditions. I received his PhD from Brigham Young University.
My primary research interests include evaluating and improving behavioral health and substance use outcomes of Veterans with alcohol and/or drug misuse conditions. Ongoing research interests include prevention of alcohol misuse among Veteran populations and development of a collaborative care management intervention for patients with complex, recurrent substance use disorders and high utilization of hospital services. Current projects include evaluating collaborative care management approaches for treating Veterans with complex and chronic substance use disorders, estimating the relative risks of serious adverse events among Veterans with PTSD who are prescribed opioids and benzodiazepines concurrently, evaluating clinical decision support interventions to reduce concurrent use of opioid and benzodiazepine medications among high-risk Veterans and validation of quality indicators for recognition and management of problematic alcohol use, and assessing the recognition and management of alcohol misuse among OEF/OIF Veterans with and without TBI.
